Conference Coverage
Conference Coverage
Adding MET TKI may overcome NSCLC resistance
ATLANTA – Combining the investigational MET inhibitor savolitinib to osimertinib was associated with responses in NSCLC resistant to EGFR-targeted...
Conference Coverage
Afatinib shows safety and efficacy among elderly
GENEVA – In a retrospective analysis of the GIDEON phase 3 trial involving patients with EGFR-positive NSCLC, there...
Conference Coverage
Larotrectinib responses support routine NTRK gene fusion testing for lung cancer
GENEVA – Although NTRK fusions are relatively infrequent in lung cancer, a subgroup analysis demonstrates an overall...
Conference Coverage
Ticagrelor doesn’t beat clopidogrel in postfibrinolysis STEMI
NEW ORLEANS – Twelve-month outcomes of TREAT study show no safety or efficacy differences.
Conference Coverage
ATA risk stratification for DTC performs well in real-world cohort
NEW ORLEANS – The risk stratification system also worked well as a predictor of disease-specific survival.
Video
Gilteritinib prolonged survival in FLT3-mutated AML
Patients with acute myeloid leukemia and FLT3-activating mutations are at increased risk for early relapse and poor overall survival.
Conference Coverage
Pooled KEYNOTE data support pembro for elderly patients with NSCLC
GENEVA – Investigators analyzed data from 264 patients 75 years or older involved in the KEYNOTE-010, KEYNOTE-024,...
Conference Coverage
Tumor-treating fields boost chemo for mesothelioma
GENEVA - Patients with malignant pleural mesothelioma who were treated with TTFields in combination with pemetrexed and...
Conference Coverage
Negotiating an employment contract? Lawyer up
PHILADELPHIA – Preparing to enter into employment contract negotiations? Lawyer up, Michael Sinha, MD, advises.
Conference Coverage
Dr. Louis Weiner: AACR presentations highlight new “transformative strategies”
ATLANTA – Studies featured during a press briefing at the AACR annual meeting, including work on a cancer preventive...
Conference Coverage
MRI predicts ALK status of NSCLC via brain lesions
GENEVA – Radiogenomic MRI signatures may be useful in identifying ALK-positive brain metastases in NSCLC, allowing...